Fig. 1 · Structure

Documents & Downloads

Alvespimycin

Cat. No. A14990 CAS 467214-20-6

Hsp90 inhibitor

Alvespimycin is a selective Hsp90 inhibitor with a GI50 of 53 nM.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
HSP90 EC50 62 nM
GRP94 EC50 65 nM

Cellular Effect

Cell Line Activity Value Description Reference
A2058 IC50 2.1 nM Cytotoxicity against human A2058 cells by MTT assay [PMID: 18929486]
A549 IC50 68 nM Cytotoxicity against human A549 cells after 72 hrs by celltiter-glo assay [PMID: 19405528]
AGS IC50 0.0036 μM Inhibition of hypoxia-induced HIF1 activation in human AGS cells by reporter gene assay [PMID: 18359631]
AGS IC50 0.036 μM Inhibition of HIF1 activation in human AGS cells assessed as inhibition of hypoxia-induced luciferase expression after 16 hrs by reporter assay [PMID: 17583950]
AGS IC50 16 μM Viability of human AGS cells under normoxic conditions after 24 hrs by MTT assay [PMID: 17583950]
AGS IC50 16 μM Cytotoxicity against human AGS cells by MTT assay [PMID: 18359631]
BT-549 IC50 17.1 μM Anticancer activity against human BT-549 cells assessed as cell growth inhibition incubated for 72 hrs by CCK-8 assay [PMID: 33650861]
CCRF-CEM IC50 2500 nM Cytotoxicity against human paclitaxel-resistant CCRF-CEM cells after 72 hrs by celltiter-96 aqueous one solution assay [PMID: 19405528]
CCRF-CEM IC50 540 nM Cytotoxicity against human CCRF-CEM cells after 72 hrs by celltiter-96 aqueous one solution assay [PMID: 19405528]
HCT-116 IC50 0.05 μM Cytotoxicity against human HCT116 cells by Alamar blue assay [PMID: 20662534]
HCT-116 IC50 0.78 μM Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTT assay [PMID: 24582477]
HCT-116 IC50 1.21 μM Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay [PMID: 24763261]
HCT-116 IC50 57 nM Cytotoxicity against human HCT116 cells after 72 hrs [PMID: 19231864]
HeLa IC50 2.06 μM Cytotoxicity against human HeLa cells by MTT assay [PMID: 18359631]
Hep 3B2 IC50 > 30 μM Inhibition of hypoxia-induced HIF1 activation in human Hep3B cells by pGL3-HRE-luciferase reporter gene assay [PMID: 19072214]
Hep 3B2 IC50 > 50 μM Viability of human Hep3B cells under normoxic conditions after 24 hrs by MTT assay [PMID: 17583950]
Hep 3B2 IC50 0.057 μM Inhibition of hypoxia-induced HIF1alpha protein accumulation in human Hep3B cells treated for 30 mins measured after 12 hrs by Western blot analysis [PMID: 20469887]
Hep 3B2 IC50 0.061 μM Inhibition of HIF1 activation in human Hep3B cells assessed as inhibition of hypoxia-induced luciferase expression after 16 hrs by reporter assay [PMID: 17583950]
Hep 3B2 IC50 0.079 μM Inhibition of hypoxia-induced VEGF protein secretion in human Hep3B cells after 16 hrs by ELISA [PMID: 20469887]
Hep 3B2 IC50 57.2 nM Inhibition of hypoxia-induced HIF1alpha protein accumulation in human Hep3B cells treated for 30 mins measured after 12 hrs by Western blot analysis [PMID: 19072214]

20 records · Scroll to view more

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 467214-20-6
Applications Hsp90 inhibitor
Formula C32H48N4O8
Molecular Weight 616.75
Synonyms 17-DMAG; KOS-1022; NSC707545
SMILES
CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCCN(C)C)C)OC)OC(=O)N)C)C)O)OC

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...